JP5750765B2 - ポリペプチド及びその抗菌または消毒用途 - Google Patents

ポリペプチド及びその抗菌または消毒用途 Download PDF

Info

Publication number
JP5750765B2
JP5750765B2 JP2011502814A JP2011502814A JP5750765B2 JP 5750765 B2 JP5750765 B2 JP 5750765B2 JP 2011502814 A JP2011502814 A JP 2011502814A JP 2011502814 A JP2011502814 A JP 2011502814A JP 5750765 B2 JP5750765 B2 JP 5750765B2
Authority
JP
Japan
Prior art keywords
polypeptide
polypeptide according
antibacterial
ulcers
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2011502814A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2010101237A1 (ja
Inventor
岳践 玄番
岳践 玄番
英樹 冨岡
英樹 冨岡
奈緒 田村
奈緒 田村
昭子 天満
昭子 天満
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Funpep Co Ltd
Original Assignee
Funpep Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Funpep Co Ltd filed Critical Funpep Co Ltd
Priority to JP2011502814A priority Critical patent/JP5750765B2/ja
Publication of JPWO2010101237A1 publication Critical patent/JPWO2010101237A1/ja
Application granted granted Critical
Publication of JP5750765B2 publication Critical patent/JP5750765B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
JP2011502814A 2009-03-06 2010-03-05 ポリペプチド及びその抗菌または消毒用途 Active JP5750765B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011502814A JP5750765B2 (ja) 2009-03-06 2010-03-05 ポリペプチド及びその抗菌または消毒用途

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2009053408 2009-03-06
JP2009053408 2009-03-06
JP2011502814A JP5750765B2 (ja) 2009-03-06 2010-03-05 ポリペプチド及びその抗菌または消毒用途
PCT/JP2010/053618 WO2010101237A1 (ja) 2009-03-06 2010-03-05 ポリペプチド及びその抗菌または消毒用途

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014199221A Division JP5845552B2 (ja) 2009-03-06 2014-09-29 ポリペプチド及びその抗菌または消毒用途

Publications (2)

Publication Number Publication Date
JPWO2010101237A1 JPWO2010101237A1 (ja) 2012-09-10
JP5750765B2 true JP5750765B2 (ja) 2015-07-22

Family

ID=42709790

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2011502814A Active JP5750765B2 (ja) 2009-03-06 2010-03-05 ポリペプチド及びその抗菌または消毒用途
JP2014199221A Active JP5845552B2 (ja) 2009-03-06 2014-09-29 ポリペプチド及びその抗菌または消毒用途
JP2015224571A Active JP6106737B2 (ja) 2009-03-06 2015-11-17 ポリペプチド及びその抗菌または消毒用途

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014199221A Active JP5845552B2 (ja) 2009-03-06 2014-09-29 ポリペプチド及びその抗菌または消毒用途
JP2015224571A Active JP6106737B2 (ja) 2009-03-06 2015-11-17 ポリペプチド及びその抗菌または消毒用途

Country Status (4)

Country Link
US (1) US8470765B2 (OSRAM)
EP (1) EP2404932B1 (OSRAM)
JP (3) JP5750765B2 (OSRAM)
WO (1) WO2010101237A1 (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5691049B2 (ja) 2008-11-28 2015-04-01 アンジェスＭｇ株式会社 血管新生誘導活性及び抗菌活性を有する新規ポリペプチド並びにその医薬用途
EP2436688B1 (en) * 2009-05-25 2014-07-09 AnGes MG, Inc. Polypeptide having antibacterial activity and angiogenesis-inducing activity and wound-healing drug containing said polypeptide
JP6013115B2 (ja) * 2011-11-22 2016-10-25 株式会社ファンペップ コラーゲンゲル収縮活性、ヒト皮膚線維芽細胞増殖活性およびヒアルロン酸産生活性を有する抗菌活性ポリペプチドを含有するスキンケア剤。
JP5971971B2 (ja) * 2012-02-16 2016-08-17 森下仁丹株式会社 抗菌活性の高いポリペプチドとその抗菌活性を阻害しない多糖類との混合物を含有するフィルムまたはシートからなる創傷被覆材
RU2502530C1 (ru) * 2012-10-09 2013-12-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Северо-Осетинская государственная медицинская академия" Министерства здравоохранения и социального развития Российской Федерации Способ лечения рожи
WO2014157485A1 (ja) 2013-03-29 2014-10-02 国立大学法人大阪大学 抗老化作用を有するペプチドおよびその利用
KR102498220B1 (ko) 2014-09-26 2023-02-08 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 신규 펩타이드 및 이의 용도
US10555988B2 (en) 2015-06-30 2020-02-11 Chain Antimicrobials Oy Antimicrobial peptides, their variants and uses
ES2808780T3 (es) 2015-06-30 2021-03-01 Chain Antimicrobials Oy Nuevos péptidos antimicrobianos, sus variantes y usos
JP6823790B2 (ja) 2015-06-30 2021-02-03 チェイン アンチマイクロバイアルズ オイＣｈａｉｎ Ａｎｔｉｍｉｃｒｏｂｉａｌｓ Ｏｙ 新規な抗菌ペプチド、その変異体及び使用
JP7266202B2 (ja) * 2018-02-19 2023-04-28 株式会社ファンケル 化粧料及び抗炎症剤
CN109847090B (zh) * 2019-03-25 2021-08-31 深圳市康乐美科技有限公司 一种具有抗菌、柔软特性的卫生巾
CN112493312A (zh) * 2020-11-23 2021-03-16 大连工业大学 一种抗菌肽Cm-CATH2防控谷物中层出镰孢菌的应用及用途
WO2025183585A1 (ru) * 2024-03-01 2025-09-04 Общество с ограниченной ответственностью "Альбоген" Пептид с антибактериальной активностью

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001012668A1 (en) 1999-08-18 2001-02-22 University Of Iowa Research Foundation Cathelicidin-derived peptides with broad spectrum antimicrobial activity
JP4524671B2 (ja) * 2003-10-29 2010-08-18 東亞合成株式会社 抗菌ペプチド及びその利用
US20050214321A1 (en) 2003-12-01 2005-09-29 Dow Global Technologies Inc. Recombinant icosahedral virus like particle production in pseudomonads
US7807176B2 (en) 2004-03-19 2010-10-05 Genomidea, Inc. Polypeptide promoting vascular endothelial cell growth
US7452856B2 (en) 2004-07-06 2008-11-18 Seikagaku Corporation Antibacterial peptide
SE0402807D0 (sv) 2004-11-17 2004-11-17 Dermagen Ab Novel antimicrobial peptides
CA2588868A1 (en) 2004-11-30 2006-06-08 Osaka University Remedy for alzheimer's disease
JP4730584B2 (ja) * 2004-12-06 2011-07-20 東亞合成株式会社 抗菌ペプチド及びその利用
CA2614295A1 (en) 2005-06-06 2006-12-14 Anges Mg, Inc. Transcription factor decoy
ES2427988T3 (es) 2005-10-05 2013-11-05 Genomidea Inc. Célula humana aislada, procedimiento para la obtención de la misma y su utilización
JPWO2007072909A1 (ja) 2005-12-22 2009-06-04 アンジェスＭｇ株式会社 新規オリゴヌクレオチド及びそれから成るＮＦ−κＢデコイ
WO2008096814A1 (ja) 2007-02-09 2008-08-14 Genomidea Inc. 新規ポリペプチド及びそれを有効成分として含有する抗菌剤
WO2008096816A1 (ja) 2007-02-09 2008-08-14 Genomidea Inc. 血管新生誘導剤及びそれに用いられるポリペプチド
JP5691049B2 (ja) 2008-11-28 2015-04-01 アンジェスＭｇ株式会社 血管新生誘導活性及び抗菌活性を有する新規ポリペプチド並びにその医薬用途
EP2436688B1 (en) 2009-05-25 2014-07-09 AnGes MG, Inc. Polypeptide having antibacterial activity and angiogenesis-inducing activity and wound-healing drug containing said polypeptide

Also Published As

Publication number Publication date
EP2404932A1 (en) 2012-01-11
JPWO2010101237A1 (ja) 2012-09-10
JP2016104726A (ja) 2016-06-09
EP2404932A4 (en) 2012-11-07
EP2404932B1 (en) 2014-07-23
JP6106737B2 (ja) 2017-04-05
JP2015038108A (ja) 2015-02-26
US20120052104A1 (en) 2012-03-01
US8470765B2 (en) 2013-06-25
WO2010101237A1 (ja) 2010-09-10
JP5845552B2 (ja) 2016-01-20

Similar Documents

Publication Publication Date Title
JP6106737B2 (ja) ポリペプチド及びその抗菌または消毒用途
JP5322108B2 (ja) 抗菌ペプチド
US20210107939A1 (en) Antimicrobial compounds
EP2735570B1 (en) Antibiotic peptide and preparation method therefor and application thereof
WO2005040192A2 (en) Human cathelicidin antimicrobial peptides
EP3405222A2 (en) Novel polypeptides and medical uses thereof
KR20200144065A (ko) Romo1 유래 항균 펩타이드 및 그 변이체
EP1896386B1 (en) Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria
KR20010052340A (ko) 인돌리시딘 유사체 및 그 사용 방법
JP5384948B2 (ja) 新規ポリペプチド及びそれを有効成分として含有する抗菌剤
EP2371840B1 (en) Novel polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes
CN101333247B (zh) 从东北林蛙皮肤中分离出的抗菌肽及其在抗菌药物中的应用
EP4423112A1 (en) Antibacterial peptide
JP2025520629A (ja) 皮膚疾患の予防および／または治療のためのペプチド－イオン液体コンジュゲート
US20150072922A1 (en) Rnase 7 antimicrobial peptides
WO2016205902A2 (en) Compositions and methods for treating biofilms
KR20010052664A (ko) 가교결합-안정화된 인돌리시딘 유사체
TWI522110B (zh) Novel antimicrobial peptides and their use
WO2022162214A1 (en) Novel selective antimicrobial fusion peptides
Umnyakova et al. Peptides and antibiotic resistance

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130227

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20130227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140729

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140929

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141006

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141027

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20141030

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150407

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20150428

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20150428

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150428

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150428

R150 Certificate of patent or registration of utility model

Ref document number: 5750765

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250